DBV Technologies

Yahoo Finance • 7 days ago

DBV Technologies Announces Resignation of Board Member

Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical compan... Full story

Yahoo Finance • 7 days ago

DBV Technologies annonce la démission d’un membre de son Conseil d’administration

Châtillon, France, le 18 septembre 2025 DBV Technologies annonce la démission d’un membre de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la “Société” ou “DBV”), une société b... Full story

Yahoo Finance • 20 days ago

DBV Technologies launches $150M ATM offering

* DBV Technologies (NASDAQ:DBVT [https://seekingalpha.com/symbol/DBVT]) filed a prospectus supplement with the SEC for an at-the-market offering up to $150M of American Depositary Shares. * Each ADS represents five ordinary shares of t... Full story

Yahoo Finance • 20 days ago

DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq

Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceu... Full story

Yahoo Finance • 20 days ago

DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq

Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une... Full story

Yahoo Finance • 22 days ago

DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a... Full story

Yahoo Finance • 22 days ago

DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment

Châtillon, France, le 3 septembre (22:30 CEST) 2025 DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP :... Full story

Yahoo Finance • 2 months ago

DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report

Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical... Full story

Yahoo Finance • 2 months ago

DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation

Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société... Full story

Yahoo Finance • 2 months ago

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharm... Full story

Yahoo Finance • 2 months ago

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société... Full story

Yahoo Finance • 2 months ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage bio... Full story

Yahoo Finance • 2 months ago

Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF

Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire b... Full story

Yahoo Finance • 3 months ago

DBV Technologies' SWOT analysis: peanut allergy patch stock poised for growth

DBV Technologies (NASDAQ:DBVT) S.A., a biopharmaceutical company focused on developing treatments for food allergies, has been making significant strides in its quest to bring Viaskin Peanut to market. The company’s stock has shown remark... Full story

Yahoo Finance • 2 years ago

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

DBV Technologies S.A. Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)... Full story

Yahoo Finance • 3 years ago

DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old

DBV Technologies S.A. Montrouge, France, March 7, 2023 DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old First patient screened at Midwest Allergy Sinus Asthm... Full story

Yahoo Finance • 3 years ago

DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update

DBV Technologies S.A. Montrouge, France, October 31, 2022 DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a... Full story

Yahoo Finance • 3 years ago

2 Biotechs That Recently Soared -- Are They Buys?

The biotech industry is volatile. Case in point: Axsome Therapeutics (NASDAQ: AXSM) and DBV Technologies (NASDAQ: DBVT) -- two small-cap biotechs -- recently saw their shares explode following positive developments. Here is the rundown on... Full story

Yahoo Finance • 3 years ago

DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting

DBV Technologies S.A. Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022Ordinary and Extraordinary General Meeting Shareholders ApprovedAll Proposed Resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010... Full story

Yahoo Finance • 3 years ago

DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results

Montrouge, France, May 2, 2022 DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results The U.S. Food and Drug Administration (FDA) has granted DBV Technologies a Type C meeting to align on the new V... Full story